In conclusion, our study conducted within real-world clinical settings revealed a noteworthy association between the use of GLP-1 RAs, including Liraglutide and Semaglutide, and a heightened risk of psychiatric outcomes, encompassing depression, anxiety, and suicidal behaviour
Although the main action of GIP is to provide a stimulus for the release of insulin after an oral glucose challenge, the hormone has also been reported to promote lipid uptake in adipocytes [12]
[DOI] [PMC free article] [PubMed] [Google Scholar] [116].Umapathysivam MM, Lee MY, Jones KL, Annink CE, Cousins CE, Trahair LG, Rayner CK, Chapman MJ, Nauck MA, Horowitz M, Deane AM, Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia, Diabetes, 63 (2014) 785790
Most users lose 5 to 15 lbs in their first 30 days